Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Creative Medical Technology Holdings (CELZ) Net Margin (2017 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Net Margin for 9 consecutive years, with 103999.83% as the latest value for Q4 2025.

  • Quarterly Net Margin fell 477270.0% to 103999.83% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 120455.48% through Dec 2025, down 6030802.0% year-over-year, with the annual reading at 120455.48% for FY2025, 6030802.0% down from the prior year.
  • Net Margin for Q4 2025 was 103999.83% at Creative Medical Technology Holdings, down from 54603.23% in the prior quarter.
  • The five-year high for Net Margin was 1786.07% in Q3 2022, with the low at 103999.83% in Q4 2025.
  • Average Net Margin over 5 years is 37844.55%, with a median of 26910.77% recorded in 2021.
  • The sharpest move saw Net Margin surged 21536391bps in 2021, then crashed -4327467bps in 2024.
  • Over 5 years, Net Margin stood at 5719.92% in 2021, then tumbled by -484bps to 33417.7% in 2022, then plummeted by -67bps to 55952.47% in 2023, then crashed by -77bps to 99227.13% in 2024, then decreased by -5bps to 103999.83% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 103999.83%, 54603.23%, and 99227.13% for Q4 2025, Q1 2025, and Q4 2024 respectively.